Skip to main content

Pesicka Edward A's Form 4 filing

Accendra Health IncACH · filed Jun 8, 2023

Accession no.
0001062993-23-013177
Filed
Jun 8, 2023
Trade date
Jun 6-7, 2023
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 2 non-derivative transactions. Open-market sales total $5.04M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Pesicka Edward ACIK 0001439487Director, Officer (President & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 6, 2023Common StockSSaleDisposed−118,927$20.86F2−$2,480,817.221,142,716Direct
Jun 7, 2023Common StockSSaleDisposed−118,927$21.56F3−$2,564,066.121,023,789Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Weighted average of the sale price range of $20.48 through $21.04

Referenced by the price of 1 transaction in Table I.

F3

Weighted average of the sale price range of $20.885 through $21.850

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)